Mycobacterial diseases, including tuberculosis (TB), leprosy, and non-tuberculous mycobacterial (NTM) infections, continue to impose a substantial global ...

A person's immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure - and differences in the focus of immune responses will help scientists ...

LONDON – The SARS-CoV-2 variant of concern that caused a wave of infection in Manaus, Brazil, in December and January has been found to be both more transmissible and to evade immunity conferred by ...

Researchers have discovered that SARS-CoV-2 hijacks three important host proteins that dampen the activity of the complement system, a key component of early antiviral immunity. This significantly ...

Researchers at the Medical University of Vienna and the Medical University of Innsbruck discovered that SARS-CoV-2 hijacks three important host proteins that dampen the activity of the complement ...

Some COVID-19 patients are testing positive after recovering in Asia, but experts say the presence of antibodies should guarantee short-term immunity ...

Conceptual illustration representing interactions between the immune system and SARS-CoV-2. The image reflects broader processes involved in antibody responses and viral adaptation during infection.

Although the general population now has at least some immunity against COVID-19, the consequences of severe disease are frequently overlooked for certain patient populations, such as those with ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

Detection of common cold coronaviruses (ccCoVs) decreased by approximately half after the widespread SARS-CoV-2 exposure and COVID-19 vaccination, whereas detection of respiratory syncytial virus (RSV ...